Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-25-001807
Filing Date
2025-05-15
Accepted
2025-05-15 08:00:10
Documents
4
Period of Report
2025-05-15

Document Format Files

Seq Description Document Type Size
1 6-K zk2533206.htm 6-K 10958
2 EXHIBIT 99.1 exhibit_99-1.htm EX-99.1 132691
3 image0.jpg GRAPHIC 26844
4 image3.jpg GRAPHIC 36627
  Complete submission text file 0001178913-25-001807.txt   232337
Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

EIN.: 813676773 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38807 | Film No.: 25948795
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)